<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Using reverse transcription of whole cellular <z:chebi fb="40" ids="33697">RNA</z:chebi> and nested PCR, we have performed experiments mixing different proportions of Epstein-Barr virus (EBV)-carrying and EBV-negative cells </plain></SENT>
<SENT sid="1" pm="."><plain>Based on the results, a method that detects <z:mp ids='MP_0001799'>viral</z:mp> transcripts for EBNA-1, EBNA-2, LMP1, and LMP2a from less than one positive cell among 10(5) negative cells was developed </plain></SENT>
<SENT sid="2" pm="."><plain>With this method we have shown that the EBV DNA positive cells among small, high-density peripheral blood B-lymphocytes of <z:mpath ids='MPATH_458'>normal</z:mpath> healthy persons express EBNA-1-<z:chebi fb="2" ids="33699">mRNA</z:chebi> but not EBNA-2 or LMP1 </plain></SENT>
<SENT sid="3" pm="."><plain>A similar EBV expression pattern is found in type I Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="4" pm="."><plain>We suggest that the expression pattern in the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells reflects the <z:mp ids='MP_0001799'>viral</z:mp> strategy in <z:mpath ids='MPATH_458'>normal</z:mpath> resting B cells and meets the requirements of latent persistence </plain></SENT>
</text></document>